BARDA Rapid Response Partnership Vehicle (RRPV)
Provides rapid-response vaccine and medicine development collaboration across many partners for urgent national threats.
The RRPV is a BARDA-sponsored, ATI-operated consortium using Other Transaction (OT) agreements to fund rapid MCM development outside FAR-based contracting. With 728 members and $809M+ awarded across 16 projects. Membership required to bid on RPPs.
BiotechDefenseMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.